di Nepi Giacomo

Avg. Two Year Performance

No purchase track record
24% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)(10%)(50%)23%24%
Sale Success Rate1 of 41 of 41 of 41 of 41 of 4

InterMune Inc.

Drugs » Biotechnology

EVP Managing Director, Europe:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--